Chronic Pain Clinical Trial
Official title:
Preliminary Test of an Integrative Intervention to Alleviate Chronic Pain and Improve Quality of Life
| Verified date | May 2017 |
| Source | Wayne State University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Chronic pain is a costly public health problem that is associated with poor quality of life. Previous research has demonstrated extensive evidence showing that pain coping is not manifested by patients in isolation but within the context of significant relationships such as marriage. For instance, a partner may avoid or reject their partners' negative emotions about pain, provide unempathic responses to their partners' pain, or change their thoughts about pain. The patient's pain experience and the couples' relationship also have a cyclical relationship, in which both can affect each other and the overall quality of life for both partners. Currently, current clinical practice does not target both partners to alleviate pain. This is highly problematic given that a number of chronic pain patients—those with interpersonal distress—often do not complete, and thus, do not benefit fully from existing treatments. Even if treatment is completed, individuals may not maintain improvements if they return to distressed social environments that undermine individual coping efforts. Thus, it is clear that new interventions derived from integrative models of individual and dyadic coping are needed to alleviate pain and suffering in patients who are at risk for poor treatment outcomes. This research study aims to develop a novel psychological intervention aimed at couples in which one partner has chronic pain. Our central hypothesis is that a theoretically integrative intervention that improves both partners' psychological flexibility (i.e., acceptance, mindfulness, values-based action) and relational flexibility (i.e., emotional disclosure, empathic responding) skills will be feasible and valid and that it will alleviate pain and improve quality of life. This is a departure from current practice, which focuses solely on the patient's individual functioning, does not address the spouse's psychological inflexibility, and does not address relationship issues.
| Status | Completed |
| Enrollment | 48 |
| Est. completion date | May 2017 |
| Est. primary completion date | May 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 21 Years and older |
| Eligibility |
Inclusion Criteria: - At least one spouse with some pain interference. - Relationship dissatisfaction. - Both partners at least 21 years old. - Couples must also be married or cohabitating for at least 2 years regardless of sexual orientation to participate in the study. Exclusion Criteria: - Current suicidal or homicidal ideation or intent - Current psychotic symptoms - Cognitive impairment - Malignancies (e.g., cancer) in either partner - Current domestic violence |
| Country | Name | City | State |
|---|---|---|---|
| United States | Wayne State University | Detroit | Michigan |
| Lead Sponsor | Collaborator |
|---|---|
| Wayne State University | National Center for Complementary and Integrative Health (NCCIH) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Treatment Credibility | Credibility of Treatment Scale | Baseline | |
| Other | Therapist Adherence | audio recordings of sessions | Participants will be followed for the duration of the intervention, an expected average of 6 weeks | |
| Other | Therapy Homework Compliance | Homework Rating Scale and time spend completing homework | Participants will be followed for the duration of the intervention, an expected average of 6 weeks | |
| Other | Therapy Session Satisfaction | Participants' satisfaction with session | Participants will be followed for the duration of the intervention, an expected average of 6 weeks | |
| Other | Intent to Complete Therapy Homework | Participants' intention to complete homework | Participants will be followed for the duration of the intervention, an expected average of 6 weeks | |
| Other | Adverse Events | Adverse event data will be collected and reported | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Primary | Change in Depressive Symptoms from Baseline to 1-month Followup | Beck Depression Inventory-II | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Primary | Change in Pain Intensity | Visual Rating Scale, Multidimensional Pain Inventory, Brief Pain Inventory | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Primary | Change in Pain Quality | McGill Pain Questionnaire | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Primary | Change in Quality of Life | Satisfaction with Life Scale | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Primary | Change in Relationship Satisfaction | Dyadic Adjustment Scale; Dyadic Adjustment Scale-7 | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Primary | Change in Sleep Quality | PROMIS Sleep Disturbance and Sleep-related Impairment Scales | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Primary | Change in Perceived Improvement | Patient Global Impression of Change | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Secondary | Change in Acceptance of Chronic Pain | Chronic Pain Acceptance Questionnaire (baseline, post-treatment, followup); Chronic Pain Acceptance Chronic Pain Acceptance Questionnaire | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Secondary | Change in Anxiety and Catastrophizing about Pain | Pain Anxiety Symptoms Scale, Pain Catastrophizing Scale (baseline, post-treatment, followup); Pain Catastrophizing Scale-Shortened Version (weekly) | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Secondary | Change in Mindfulness | Five Facet Mindfulness Scale | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Secondary | Change in Values-Based Action | Chronic Pain Values Inventory | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Secondary | Change in Dispositional Empathy | Interpersonal Reactivity Index | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Secondary | Change in Emotional Expression | Ambivalence Over Emotional Expression Questionnaire, Holding Back Scale | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Secondary | Change in Emotional Validation and Invalidation | Coded from Couple Discussion Task | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks | |
| Secondary | Change in Partner-perceived Empathy | Perceived Partner Responsiveness Scale | Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|